Delta-Fly Pharma Inc (4598) Stock Price & News

All values in JPY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	413.00M	335.00M	297.00M	365.00M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	60.00M	68.00M	8.00M	55.00M
Operating expense	473.00M	403.00M	371.00M	420.00M
Total operating expenses	473.00M	403.00M	371.00M	420.00M
Operating income	-473.00M	-403.00M	-371.00M	-420.00M
Other non operating income	1.00M	-4.00M	-5.00M	-1.00M
EBT including unusual items	-473.00M	-407.00M	-376.00M	-422.00M
EBT excluding unusual items	-473.00M	-407.00M	-376.00M	-422.00M
Income tax expense	1.00M	-	1.00M	-
Effective tax rate	-0.21%	-	-0.27%	-
Other operating expenses	-	-	66.00M	-
Net income	-474.00M	-407.00M	-377.00M	-422.00M
Net profit margin	-	-	-	-
Earnings per share	-	-	-	-
Interest and investment income	-	-	-	-
Interest expense	-	-	-	-
Net interest expenses	-	-	-	-
Depreciation and amortization charges	-	-	-	-
EBITDA	-472.75M	-402.75M	-370.75M	-419.75M
Gain or loss from assets sale	-	-	-	-

Finance